SAA1 is highly expressed during inflammation and has been identified as a potential Wilms’ tumor marker [62], as one of a two-protein signature model for prognosis prediction in metastatic RCC [63], and as a predictor in fatal outcome in RCC [64]. Here, SAA1 is linked to renal cell carcinoma.